Raymond Scott Turner, MD, PhD

Affiliations:	1979-1984	Pharmacology	Emory University, Atlanta, GA
	1984-1988	Medicine	Emory University, Atlanta, GA
	1988-1989	Medicine	University of Pennsylvania, Philadelphia, PA, United States
	1989-1995	Neurology	University of Pennsylvania, Philadelphia, PA, United States
	1995-2008	Neurology	University of Michigan, Ann Arbor, Ann Arbor, MI
	2008-	Neurology	Georgetown University, Washington, DC

Area:

Alzheimer's disease

Website:

http://memory.georgetown.edu

Google:

"Raymond Scott Turner"

Bio:

The mission of the Georgetown University Memory Disorders Program is to prevent and treat Alzheimer's disease and related dementias by conducting innovative research, educating and training healthcare professionals and the public on research advances, and offering state-of-the-art clinical care.

Mean distance: 14.18 (cluster 24)

Cross-listing: Alzheimer's Tree

Tree Publications Grants Similar researchers PubMed Report error

Parents

J.-F. Kuo	grad student	1979-1985	Emory
Murray Grossman	post-doc	1992-1995	Georgetown
Virginia Man-Yee Lee	post-doc	1992-1995	Penn
John Q. Trojanowski	post-doc	1992-1995	Penn

Children

Gwendalyn DiAnn King	grad student	2000-2004	University of Michigan
Lauren E. Ullrich	grad student	2010-2014	Georgetown

Collaborators

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Meyer AM, Tippett DC, Turner RS, et al. (2018) Long-Term maintenance of anomia treatment effects in primary progressive aphasia. Neuropsychological Rehabilitation. 1-25
Meyer A, Getz H, Snider S, et al. (2013) Remediation and Prophylaxis of Anomia in Primary Progressive Aphasia. Procedia, Social and Behavioral Sciences. 94: 275-276
King GD, Cherian K, Turner RS. (2004) X11alpha impairs gamma- but not beta-cleavage of amyloid precursor protein. Journal of Neurochemistry. 88: 971-82
King GD, Perez RG, Steinhilb ML, et al. (2003) X11alpha modulates secretory and endocytic trafficking and metabolism of amyloid precursor protein: mutational analysis of the YENPTY sequence. Neuroscience. 120: 143-54
Turner RS, Kenyon LC, Trojanowski JQ, et al. (1996) Clinical, neuroimaging, and pathologic features of progressive nonfluent aphasia. Annals of Neurology. 39: 166-73
Cook DG, Turner RS, Kolson DL, et al. (1996) Vaccinia virus serves as an efficient vector for expressing heterologous proteins in human NTera 2 neurons. The Journal of Comparative Neurology. 374: 481-92
Turner RS, Suzuki N, Chyung AS, et al. (1996) Amyloids beta40 and beta42 are generated intracellularly in cultured human neurons and their secretion increases with maturation. The Journal of Biological Chemistry. 271: 8966-70
Wertkin AM, Turner RS, Pleasure SJ, et al. (1993) Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides. Proceedings of the National Academy of Sciences of the United States of America. 90: 9513-7
Kuo JF, Shoji M, Girard PR, et al. (1986) Phospholipid/calcium-dependent protein kinase (protein kinase C) system: a major site of bioregulation. Advances in Enzyme Regulation. 25: 387-400
Su HD, Kemp BE, Turner RS, et al. (1986) Synthetic myelin basic protein peptide analogs are specific inhibitors of phospholipid/calcium-dependent protein kinase (protein kinase C). Biochemical and Biophysical Research Communications. 134: 78-84